|
| 37530387 | Real-world time to discontinuation of first-line venetoclaxâ¿¿+â¿¿obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma. | | 2023 |
| 37641660 | Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia. | | 2023 |
| 37476983 | Time to next treatment in patients with chronic lymphocytic leukemia initiating first-line ibrutinib or acalabrutinib. | | 2023 |
| 37081408 | Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database. | | 2023 |
| 36867350 | Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database. | | 2023 |
| 34751912 | Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study. | Advances in Therapy | 2022 |
| 35611118 | Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes. | | 2022 |
| 35239168 | Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study. | Advances in Therapy | 2022 |
| 35133630 | A Feasibility Study: Testing Whether a Sleep Application Providing Objective Sleep Data to Physicians Improves Patient-Physician Communication Regarding Sleep Experiences, Habits, and Behaviors. | Advances in Therapy | 2022 |
| 35001893 | Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review. | Journal of Alzheimer's Disease | 2022 |
| 34420974 | Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients. | Journal of Alzheimer's Disease | 2021 |
| 33112008 | Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey. | Eur J Cancer Care (Engl) | 2021 |
| 34463922 | Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant. | Advances in Therapy | 2021 |
| 33369293 | A Real-World Assessment of Outcomes in Schizophrenia Patients According to Treatment Response. | primary care companion for CNS disorders, The | 2020 |
| 31685294 | Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States. | American Journal of Kidney Diseases | 2020 |
| 32106685 | Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim. | Annals of Pharmacotherapy | 2020 |
| 32934955 | Assessment of Real-Life Outcomes in Schizophrenia Patients according to Compliance. | | 2020 |
| 30508013 | Biosimilar Filgrastim Use in the United States vs the European Union and Japan-Why Does It Lag Behind and What Can Be Done? | JAMA Oncol | 2019 |
| 28737062 | Community-level electronic prescribing and adverse drug event hospitalizations among older adults. | Health Informatics Journal | 2019 |
| 30557871 | Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores. | American Journal of Nephrology | 2019 |
| 30598200 | EDITORIAL COMMENT. | Urology | 2019 |
| 29289356 | Editorial Comment. | Urology | 2018 |
| 30169374 | Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework. | Am J Ther | 2018 |
| 29853290 | Editorial Comment. | Urology | 2018 |
| 30031596 | Fluoroquinolone-associated suicide. | Eur J Intern Med | 2018 |
| 28208180 | Improving the Evidence Base for Delivery of High-Quality Cancer Care. | JAMA Oncol | 2017 |
| 28504901 | Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. | J Oncol Pract | 2017 |
| 28635055 | Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR). | Cancer Med | 2017 |
| 28941944 | Editorial Comment. | Urology | 2017 |
| 28845476 | Opioid Prescription Drug Use and Expenditures in US Outpatient Physician Offices: Evidence from Two Nationally Representative Surveys. | Cancer Ther Oncol Int J | 2017 |
| 28625690 | What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening? | Clin Genitourin Cancer | 2017 |
| 28562498 | Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians. | J Contin Educ Health Prof | 2017 |
| 29195633 | Effects of women's autonomy on maternal healthcare utilization in Bangladesh: Evidence from a national survey. | Sexual and Reproductive Healthcare | 2017 |
| 27814940 | Health-related quality of life among adults 65 years and older in the United States, 2011-2012: a multilevel small area estimation approach. | Ann Epidemiol | 2017 |
| 27819247 | Generic oncology drugs: are they all safe? | Lancet Oncol | 2016 |
| 27179946 | Editorial Comment. | Urology | 2016 |
| 26955658 | Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network. | J Community Support Oncol | 2016 |
| 26393917 | A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data. | Biometrics | 2016 |
| 25456378 | Regulatory and clinical considerations for biosimilar oncology drugs. | Lancet Oncol | 2014 |
| 24829884 | Rituximab and biosimilars - equivalence and reciprocity. | Biosimilars | 2013 |
| 23530950 | Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). | Br J Haematol | 2013 |
| 23712701 | Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States. | Pharmacotherapy | 2013 |
| 23077434 | Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States. | J Oncol Pract | 2012 |
| 22427934 | Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. | PLoS One | 2012 |
| 22692632 | Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). | J Gen Intern Med | 2012 |
| 22833806 | Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. | Clin Kidney J | 2012 |
| 23111862 | Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). | Semin Thromb Hemost | 2012 |
| 23111861 | A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). | Semin Thromb Hemost | 2012 |
| 23598851 | A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. | J Oncol Pract | 2012 |
| 21595611 | Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. | Expert Opin Drug Saf | 2011 |